Publication Beamlines Strategic Pillar
Stille, Julia K.; Tjutrins, Jevgenijs; Wang, Guanyu; Venegas, Felipe A.; Hennecker, Christopher et al. (2022). Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. European Journal of Medicinal Chemistry 229, 114046. 10.1016/j.ejmech.2021.114046. [PDB: 7mlf] CMCF-BM Health
Štrukil, Vjekoslav; Gracin, Davor; Magdysyuk, Oxana V.; Dinnebier, Robert E.; Friščić, Tomislav et al. (2015). Trapping Reactive Intermediates by Mechanochemistry: Elusive ArylN-Thiocarbamoylbenzotriazoles as Bench-Stable Reagents. Angewandte Chemie - International Edition 54(29) , 8440-8443. 10.1002/anie.201502026. CMCF-BM Materials
Suits, Michael D.L.; Pluvinage, Benjamin; Law, Adrienne; Liu, Yan; Palma, Angelina S. et al. (2014). Conformational Analysis of the Streptococcus pneumoniae Hyaluronate Lyase and Characterization of Its Hyaluronan-specific Carbohydrate-binding Module. Journal of Biological Chemistry 289(39) , 27264-27277. 10.1074/jbc.m114.578435. [PDB: 4d0q] CMCF-BM Health
Sychantha, David; Little, Dustin J; Chapman, Robert N; Boons, Geert-Jan; Robinson, Howard et al. (2017). PatB1 is an O-acetyltransferase that decorates secondary cell wall polysaccharides. Nature Chemical Biology 14(1) , 79-85. 10.1038/nchembio.2509. [PDB: 5v8e] CMCF-BM Health
Tamura, Kazune; Foley, Matthew H.; Gardill, Bernd R.; Dejean, Guillaume; Schnizlein, Matthew et al. (2019). Surface glycan-binding proteins are essential for cereal beta-glucan utilization by the human gut symbiont Bacteroides ovatus. Cellular and Molecular Life Sciences 76(21) . 10.1007/s00018-019-03115-3. [PDB: 6e9b] CMCF-BM Health
Taylor, Jared M.; Dwyer, Patrick J.; Reid, Joel W.; Gelfand, Benjamin S.; Lim, Dae-woon et al. (2018). Holding Open Micropores with Water: Hydrogen-Bonded Networks Supported by Hexaaquachromium(III) Cations. Chem 4(4) , 868-878. 10.1016/j.chempr.2018.02.004. CMCF-BM Materials
Throner, Scott; Feng, Tianshu; Andersen, Jannik N.; Bandi, Madhavi; Engel, Justin L. et al. (2025). Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor. Bioorganic and Medicinal Chemistry Letters 124, 130262. 10.1016/j.bmcl.2025.130262. [PDB: 9n9y] CMCF-BM Health